Package 65219-552-02

{"route": ["INTRAVENOUS"], "spl_id": "510bc71b-20e4-428a-8fc2-29c9fc20f2f3", "openfda": {"nui": ["N0000175584"], "unii": ["A8Q8I19Q20"], "rxcui": ["1796419", "1796424"], "spl_set_id": ["a5daa583-4965-4564-ad87-41ffe6c08a11"], "pharm_class_epc": ["Folate Analog Metabolic Inhibitor [EPC]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (65219-552-02)  / 2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "65219-552-02", "marketing_start_date": "20221115"}], "brand_name": "Pralatrexate", "product_id": "65219-552_510bc71b-20e4-428a-8fc2-29c9fc20f2f3", "dosage_form": "INJECTION", "pharm_class": ["Folate Analog Metabolic Inhibitor [EPC]"], "product_ndc": "65219-552", "generic_name": "Pralatrexate", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pralatrexate", "active_ingredients": [{"name": "PRALATREXATE", "strength": "40 mg/2mL"}], "application_number": "NDA022468", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20221115", "listing_expiration_date": "20261231"}